Alert: Major Price Advance (9/24/25)-Zevra Therapeutics Inc (NASDAQ: ZVRA).

out_logo_500#72314.jpg

On 9/24/25, Zevra Therapeutics Inc (NASDAQ: ZVRA) stock enjoyed a major increase of 10.4%, closing at $8.95. Moreover, trading volume in this advance was exceptionally high at 441% of normal. The stock has risen 23.3% during the last week and has been strong relative to the market over the last nine months.

out_mm#72314.jpg

Current PriceTarget Research Rating

Zevra Therapeutics has a current Value Trend Rating of C (High Neutral). The Value Trend Rating reflects consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Zevra Therapeutics has a neutral Appreciation Score of 51 and a slightly positive Power Rating of 69, resulting in the High Neutral Value Trend Rating.

Rating Review

In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.

Be the first to comment

Leave a Reply

Your email address will not be published.


*